Glp-1 Mimetics Employed During Ramadan Fasting

GlucagonLike Peptide1 (GLP1) during Ramadan

Hypoglycemia, characterized by low blood sugar levels, could also result from fasting during Ramadan . The GLP-1 (glucagon-like peptide-1) hormone plays a significant role in regulating glucose metabolism and insulin secretion, and Ramadan fasting can affect its production and release in the gut.

This guide provides essential tips for fasting during Ramadan while using GLP-1 medications like Mounjaro. Learn how to manage medication timing, prevent side effects and maintain energy levels.

Managing GLP

As Ramadan approaches, many patients taking GLP-1 receptor agonist therapy with medications such as Mounjaro (tirzepatide) and Wegovy (semaglutide) may have questions about managing their treatment during fasting hours.

Furthermore, visual representations like the one above help us fully grasp the concept of Glp-1 Mimetics Employed During Ramadan Fasting.

Safety and efficacy of glucagon

Data on the use of glucagon-like peptide-1 receptor agonists ( GLP -1RAs) in individuals with type 2 diabetes mellitus (T2DM) during Ramadan fasting is limited. No meta-analysis has summarized the safety and effectiveness of GLP -1RAs in these ...

This study compared glycemic metrics and adverse events in fasting and non- fasting people with T1D using GLP1 -RA during Ramadan . Methods: This prospective observational study included 20 people with T1D who were on a stable GLP1 -RA dose and used continuous glucose monitoring (CGM) devices.